LIMK1 and PKM as Integratively Identified Transcriptomic Signatures in Inflammatory Bowel Disease
Authors:
- 12 August 2026
- journal article
- research article
- Published by SAGE Publications in OMICS: A Journal of Integrative Biology
- Vol. 30 (10) , 609-630
Abstract
Inflammatory bowel disease (IBD) involves complex immunometabolic dysregulation. Mitochondria-associated endoplasmic reticulum membranes (MAMs) link metabolic adaptation and inflammatory signaling, but gene expression features associated with MAM-related transcriptomic states in IBD remain unclear. Public transcriptomic datasets were integrated with a curated MAM-related gene set and herbal target information. Differential expression analysis, weighted gene coexpression network analysis, and machine learning-assisted feature selection were used to identify candidate genes. A two-gene nomogram was constructed and evaluated in discovery and independent validation datasets. Functional enrichment, immune deconvolution, regulatory network prediction, molecular docking, 200-ns molecular dynamics simulations, and preliminary quantitative polymerase chain reaction validation were performed. LIMK1 and PKM were identified as candidate transcriptomic signature genes associated with IBD status and MAM-related transcriptional states, showing discriminatory performance in independent datasets. Both genes were associated with cytokine–cytokine receptor interaction and drug metabolism–cytochrome P450 pathways and were linked to macrophage-related immune states. Structural analyses suggested stable predicted binding between PKM and 1-(4-hydroxybenzyl)-4-methoxy-9,10-dihydrophenanthrene-2,7-diol and structurally plausible interactions between LIMK1 and palmatine. Preliminary tissue-level validation supported the disease-associated expression pattern of PKM , whereas LIMK1 showed a consistent but nonsignificant upward trend. LIMK1 and PKM may represent candidate transcriptomic signatures associated with MAM-related regulatory states in IBD. These findings should be interpreted as hypothesis-generating associations rather than evidence of MAM localization, functional causality, or therapeutic efficacy. Further protein-level and functional validation is required.Keywords
Funding Information
- The Fifth Batch of National Outstanding Chinese Medicine Clinical Talent Training Program, State Administration of Traditional Chinese Medicine ([2022] No. 1)
- Superior Specialized Department of Spleen and Stomach Diseases, State Administration of Traditional Chinese Medicine ([2024] No. 90)
This publication has 66 references indexed in Scilit:
- Regulation and signaling of the LIM domain kinasesBioEssays, 2024
- ORMDL3 regulates NLRP3 inflammasome activation by maintaining ER-mitochondria contacts in human macrophages and dictates ulcerative colitis patient outcomeJournal of Biological Chemistry, 2024
- Network analysis of monoamines involved in anxiety-like behavior in a rat model of osteoarthritisPharmacological Reports, 2024
- Identification and Immune Characteristics Study of Pyroptosis‑Related Genes in EndometriosisBiochemical Genetics, 2023
- Integration and deconvolution methodology deciphering prognosis-related signatures in lung adenocarcinomaJournal of Cancer Research and Clinical Oncology, 2023
- Visualizing Mitochondrial Form and Function within the CellTrends in Molecular Medicine, 2020
- Macrophage plasticity, polarization, and function in health and diseaseJournal of Cellular Physiology, 2018
- Profiling Tumor Infiltrating Immune Cells with CIBERSORT2018
- The Adaptor MAVS Promotes NLRP3 Mitochondrial Localization and Inflammasome ActivationCell, 2013
- Cytochrome P450 enzymes in drug metabolism: Regulation of gene expression, enzyme activities, and impact of genetic variationPharmacology & Therapeutics, 2013